| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Head Of U.s. Commercial
1 company
Fox Christine is an EVP, Head Of U.s. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $3.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sale+OE | 28,229 | $24.78 | $699,523.09 | -30.7% | +40.5% | - | |
| Nov 14, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sell | 30,000 | $25.11 | $753,321.00 | -51.4% | +33.5% | - | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sale+OE | 6,181 | $15.80 | $97,639.02 | -4.9% | +8.1% | +99.7% | |
| Nov 20, 2024 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sale+OE | 19,388 | $16.87 | $327,085.25 | -30.5% | -2.7% | +42.6% |